The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity - Wikidata - awgldk - TriplyDB

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

http://www.wikidata.org/entity/Q34512981

about

A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis Mitochondrial morphology in metabolic diseases Mitochondrial dynamics in diabetic cardiomyopathy Original Research: Evaluation of pulmonary response to inhaled tungsten (IV) oxide nanoparticles in golden Syrian hamsters Environmental pollution: a tangible risk for NAFLD pathogenesis Lipotoxicity in the liver.Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis.Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats.Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation.Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.Involvement of the p62/NRF2 signal transduction pathway on erythrophagocytosis.Toward a chemical marker for inflammatory disease: a fluorescent probe for membrane-localized thioredoxin.Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease.High fat diet feeding exaggerates perfluorooctanoic acid-induced liver injury in mice via modulating multiple metabolic pathways.Obesity, diabetes mellitus, and liver fibrosis.Dietary zinc deficiency exaggerates ethanol-induced liver injury in mice: involvement of intrahepatic and extrahepatic factors Eucommia ulmoides cortex, geniposide and aucubin regulate lipotoxicity through the inhibition of lysosomal BAX.Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity Mechanisms of lipotoxicity in NAFLD and clinical implications Arsenic induces apoptosis by the lysosomal-mitochondrial pathway in INS-1 cells.Diagnosis and evaluation of nonalcoholic fatty liver disease.Elongation Factor 1A-1 Is a Mediator of Hepatocyte Lipotoxicity Partly through Its Canonical Function in Protein Synthesis The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications.Atorvastatin inhibits the apoptosis of human umbilical vein endothelial cells induced by angiotensin II via the lysosomal-mitochondrial axis.Etiopathogenesis of nonalcoholic steatohepatitis: role of obesity, insulin resistance and mechanisms of hepatotoxicity.Investigating Nonalcoholic Fatty Liver Disease in a Liver-on-a-Chip Microfluidic Device Hepatitis C virus infection and nonalcoholic steatohepatitis Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: new evidence on the potential therapeutic mechanism Sodium 4-phenylbutyrate prevents murine dietary steatohepatitis caused by trans-fatty acid plus fructose.Adipocyte hypertrophy is associated with lysosomal permeability both in vivo and in vitro: role in adipose tissue inflammation Oxidative stress contributes to abnormal glucose metabolism and insulin sensitivity in two hyperlipidemia models Glycosphingolipids and cell death: one aim, many ways Lysosomal instability and cathepsin B release during acetaminophen hepatotoxicity.Lipid-induced hepatocyte-derived extracellular vesicles regulate hepatic stellate cell via microRNAs targeting PPAR-γ.Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential Hepatic and serum lipid signatures specific to nonalcoholic steatohepatitis in murine models.

P2860

Q26744488-CCA9B9F1-4B53-4849-8ADA-DE990E5FB71B Q26766533-D40258CE-E3A9-4B29-9263-90FA1EA9C1F6 Q28385060-DB88878B-EC21-4DBA-B6FF-74AA00FD3B99 Q28395223-0B491C8E-16F0-4D50-B6BA-E4EF744FA590 Q28397619-7C216F98-887A-44E4-9B10-AFD7CA9355DF Q28661241-A0F51C2F-E57B-4666-B428-E1F416C8C935 Q30355131-07E88DC5-4E7D-4B59-89C3-607A091EAF9E Q30447993-96611578-70BC-47CA-8CBA-290776BB2156 Q33567477-BD51751F-E6AA-42D5-85C4-1E3A9920818E Q33755829-33A3298B-52DE-475F-8DEE-1875E654CA33 Q33765372-A0A0BCD4-DA0F-4FCF-B865-7B604100F33F Q33918363-2A18A6AF-0908-4C0D-AA95-4DA59930194E Q34489826-DEB8874E-3F78-4022-A3C5-E7813ABF8323 Q34626474-932FAD1C-7A28-4AC6-B53C-5D4E619CE2FB Q34692127-ABF11229-A384-4E88-8495-4C3BF0E868BF Q34979922-7264B017-DB0D-4624-987D-366560171FDD Q35025292-8E86B294-A414-45E4-BF5D-ED5F08243A19 Q35106009-4730EEC9-C28F-40E4-9E1F-4732E77EE70A Q35120903-D9025D00-B650-465B-B4E0-C641C609D2CE Q35132916-CB2C636E-2389-4B48-9142-E2175BCDD922 Q35215838-B42498FA-1B02-4ADB-9815-46898DA8D492 Q35495753-EA9D2403-1057-4BE2-B7F4-A09C85CBDD27 Q35671675-9BBC1C40-979F-44C4-91B3-1A2163CF4E17 Q35899658-F1AA1CD6-C5D0-4CF3-9ED3-2A1802E113A4 Q35931190-9481E0F6-1EF1-43E3-BF83-F00C406967CB Q36072142-17485B8B-3CDC-438F-85A7-73D967B00779 Q36076151-6FB1397D-5594-44F6-A75A-9E69A94AFC24 Q36082853-F46B59D6-8E71-49B4-8D7D-55BC13A78DA7 Q36179898-4369C960-0BBD-4C58-949B-F13E997AAFFD Q36199008-E37DB55D-14DC-4041-84BA-925C021B3075 Q36265379-0D1107F7-B18D-47E1-AED4-A0430B9C2437 Q36309443-63C39D48-5812-4B39-B085-56D08611C2E9 Q36375364-E808B153-A8DA-41AC-B37F-2FFC760D1B08 Q36405917-F5ADAD3E-EFF8-4609-B96C-C49AD6F2A209 Q36409780-14FF8E9A-2B1C-4D10-8145-5582AD9F7B38 Q36466498-CD671DA1-BFC8-45B8-A1A8-D566F78E1AF8 Q36818022-6F37B1BC-178D-47BF-B4CD-4389427F9797 Q37062751-3A91D9BF-C3B7-44C7-A093-D8E4B601F6BE Q37161711-F9E41905-CF96-4DBE-B0D9-D80542579FA5 Q37166770-1D901068-196F-4938-9C01-2DABB19BD690

P2860

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

http://www.wikidata.org/entity/Q34512981

description

2008 nî lūn-bûn

@nan

2008 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@ast

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@en

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@nl

type

label

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@ast

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@en

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@nl

prefLabel

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@ast

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@en

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@nl

P1433

Q34512981-8C345C24-BCD6-425A-B457-66BB5500DF20

P1476

Q34512981-30F37A02-BB37-4FAE-844E-5B5A63AB6281

P2093

Q34512981-084F5E3C-CC2E-41E7-B926-59F2E0B3B457

Q34512981-30A2F5CC-9601-4424-94DC-5E83EA0D10C0

Q34512981-D9CB0C2C-C61A-4056-9117-A05E238D8696

P2860

Q34512981-01E47786-123E-4FBA-A37E-2D8B294F1A77

Q34512981-0578B5E8-6832-4E00-A3AA-BDD95892F947

Q34512981-150B798C-A0CE-41F5-A4B2-92E463EB2962

Q34512981-1A764EC9-D20C-4C5A-A693-C47A37A8167B

Q34512981-2B9690AB-704A-4B1D-A504-247B0E9600C7

Q34512981-30D5C878-4C49-4321-A9D9-0E407B719827

Q34512981-3DE4DD8D-5C23-4BB6-AC2F-FF8BCA71A695

Q34512981-4BC74A39-B99A-4206-B3C9-2C8547E3169D

Q34512981-4E8FCEF2-E7DD-4C08-854E-A0A3D3BB8611

Q34512981-5186ECF8-9D23-4CA9-B5B7-38FA4EDD3A01

P304

Q34512981-CFA530C9-CD85-422E-8CEB-0DB1F837D834

P31

Q34512981-C5B2A615-74A3-48C4-8253-D60ABA3549FE

P356

Q34512981-BD192222-BC90-4D47-A309-A725581516B1

P407

Q34512981-C2C6D51E-8B87-4442-980D-322DDF86227D

P433

Q34512981-460F28EB-C2F5-43FA-AC48-D93A81DEB935

P478

Q34512981-A221ABD8-FC0A-48F7-AEC0-36F006FC67FD

P50

Q34512981-7C4514CC-9166-4118-A887-3BDBBA0BA022

Q34512981-965CF8B1-7DCC-4D82-A310-D4BC0D9B4ED9

P577

Q34512981-50026C89-36FE-49AC-9688-EC3058BC8EC3

P5875

Q34512981-07B9FB98-3800-4293-8D6B-5A3F4A1C26BE

P698

Q34512981-6BB4368D-87C8-4581-A2F5-0853211354FE

P921

Q34512981-10038339-8851-4A89-81C2-D7496525D7C2

P932

Q34512981-360663B3-A27E-4AE1-9DA8-368233B7354E

P356

P1433

P1476

The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity

@en

P2093

Ariel E Feldstein

http://www.w3.org/2001/XMLSchema#string

Thomas M McIntyre

http://www.w3.org/2001/XMLSchema#string

ZhengZheng Li

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease

Steatohepatitis: a tale of two "hits"?

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

Molecular mediators of hepatic steatosis and liver injury

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

Nonalcoholic fatty liver disease

Mitochondria in nonalcoholic fatty liver disease.

Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines.

Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.

Apoptotic pathways: the roads to ruin.

P304

1495-1503

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/HEP.22183

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

Gregory J Gores

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5632064

http://www.w3.org/2001/XMLSchema#string

P698

18220271

http://www.w3.org/2001/XMLSchema#string

P921

P932

3025414

http://www.w3.org/2001/XMLSchema#string